To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

NCT04566666 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Plaque Psoriasis

Interventions

DRUG: Placebo
DRUG: SCD-044_Low Dose (Dose 1)
DRUG: SCD-044_Intermediate Dose (Dose 2)
DRUG: SCD-044_High Dose (Dose 3)

Sponsor

Sun Pharmaceutical Industries Limited